Healthcare Markets Initiative
Healthcare Markets Initiative
U.S. healthcare markets suffer from both overuse and underuse. The challenge is developing the appropriate incentives that eliminate the inefficiencies which lead to some services being too expensive and reimbursements for other services being too low. The Healthcare Markets Initiative advances market-based solutions to health policy challenges in a variety of areas including rare diseases, medical devices and mental health.
Featured Research View All
Mitigating the Inflation Reduction Act’s Adverse Impacts on the Prescription Drug Market
This paper provides three recommendations to steer the potential effects of the IRA toward its goal of improving patient access while encouraging innovation.
Experts: Dana Goldman, Joseph Grogan, Darius Lakdawalla, Barry Liden, Erin Trish
Healthcare Markets Researchers
Medical Device Regulation and Reimbursement: What the Pandemic Revealed
Schaeffer Center Nonresident Senior Fellow and Former Director of the Domestic Policy Council Joe Grogan and AEI Senior Fellow and Former FDA Commissioner Scott Gottlieb joined Schaeffer Center Co-Director Erin Trish to discuss the challenges and opportunities facing the FDA and CMS in an age of breakthrough medical devices.
Featured Perspectives View All
The Agency Keeping Alzheimer’s Drugs from Patients
The Centers for Medicare and Medicaid Services refuses to approve breakthrough drugs.
Experts: Joseph Grogan
Featured Article
Medicare Advantage Enrollment Outpaces —and Nearly Overcomes— Traditional Medicare, New USC Study Finds
Medicare Advantage plans have seen a more than 300% increase in enrollment—with payment policy yet to catch up.
Get Involved
Learn more about HMI, including opportunities to collaborate